Bayer BAYRY announced that it has submitted a new drug application (“NDA”) to the FDA seeking approval for its ...

Italy-based Bracco Imaging and Subtle Medical have obtained an EU CE mark for AiMIFY, a jointly developed software designed ...

Bracco Imaging S.p.A., a global leader in diagnostic imaging, and Subtle Medical, Inc., a pioneering innovator in artificial ...

Berlin: Bayer has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ...

Bayer seeks US FDA approval for contrast agent, gadoquatrane for contrast-enhanced MRI of the CNS and other body regions: Berlin Wednesday, June 18, 2025, 09:00 Hrs [IST] Bayer an ...

Imaging System Market Outlook 2025-2034Luton, Bedfordshire, United Kingdom, June 20, 2025 (GLOBE NEWSWIRE) -- The global medical near-infrared fluorescence (NIRF) imaging system market is witnessing ...

Nanomaterials are improving ophthalmic care by enhancing drug delivery, diagnostic imaging, and tissue regeneration. This ...

The company's application included a submitted dose of 0.04 millimole gadolinium per kilogram of body weight. If approved, gadoquatrane would become the lowest dose macrocyclic gadolinium-based ...

GlobalData’s research reveals that the country currently accounts for approximately 25 per cent of the Asia-Pacific ...

Brain death determination sits at the fraught intersection of critical-care medicine, ethics, and organ-donation logistics.